"Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration" Final version

Similar documents
Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

November 18, 2011 MEASURES TO IMPROVE THE OPERATIONS OF THE CLIMATE INVESTMENT FUNDS

A New Platform for escience and data research into the European Ecosystem.

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

Christina Miller Director, UK Research Office

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Brief presentation of the results Ioana ISPAS ERA NET COFUND Expert Group

COLLIDE International Award 2018

Reputation enhanced by innovation - Call for proposals in module 3

WG/STAIR. Knut Blind, STAIR Chairman

Committee on Development and Intellectual Property (CDIP)

Brief to the. Senate Standing Committee on Social Affairs, Science and Technology. Dr. Eliot A. Phillipson President and CEO

Biometrics and Standardization. Presentation to BioSec 2nd Open Workshop, 19th and 20th January, 2005

Getting the evidence: Using research in policy making

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

The UNISDR Global Science & Technology Advisory Group for the implementation of the Sendai Framework for Disaster Risk Reduction UNISDR

Consultation on Long Term sustainability of Research Infrastructures

NCRIS Capability 5.7: Population Health and Clinical Data Linkage

Public Private Partnerships & Idea selection

Science and Heritage Programme Call for Research Cluster Proposals - Specification

ADVANCING KNOWLEDGE. FOR CANADA S FUTURE Enabling excellence, building partnerships, connecting research to canadians SSHRC S STRATEGIC PLAN TO 2020

1. Introduction. defining and producing new materials with advanced properties, or optimizing industrial processes.

SSHRC S KNOWLEDGE MOBILIZATION STRATEGY

IEA Wind Task 32. David Schlipf Operating Agent SWE University of Stuttgart Germany

HORIZON Overview of structure and funding opportunities for EuNetAir partners and network

Realising the FNH-RI: Roadmap. Karin Zimmermann (Wageningen Economic Research [WUR], NL)

COST European Cooperation in Science and Technology

Research and Innovation Strategy and Action Plan UPDATE Advancing knowledge and transforming lives through education and research

Synergies and Complementarities with EU Research & Innovation Policy

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities

December Eucomed HTA Position Paper UK support from ABHI

DoReMi-MELODI Training and Education Forum Introduction and background

Technical Assistance. Programme of Activities

Conclusions on the future of information and communication technologies research, innovation and infrastructures

Joint Programming Initiative Healthy and Productive Seas and Oceans

II. The mandates, activities and outputs of the Technology Executive Committee

RESEARCH AND INNOVATION STRATEGY. ANZPAA National Institute of Forensic Science

3. How to prepare a successful proposal?

Policy Partnership on Science, Technology and Innovation Strategic Plan ( ) (Endorsed)

Pan-Canadian Trust Framework Overview

Canada-Italy Innovation Award Call for Proposals

Terms of Reference. Call for Experts in the field of Foresight and ICT

Sustainable Society Network+ Research Call

CO-ORDINATION MECHANISMS FOR DIGITISATION POLICIES AND PROGRAMMES:

The New Delhi Communiqué

SafeNano Norway in from concept to reality?

Systems Approaches to Health and Wellbeing in the Changing Urban Environment

Extract of Advance copy of the Report of the International Conference on Chemicals Management on the work of its second session

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

The TTO circle workshop on "Technology Transfer in Nanotechnology"

European Technology Platforms

Committee on Development and Intellectual Property (CDIP)

European-South African Cooperation in Scientific and Technical Research

Medical Technology Association of NZ. Proposed European Union/New Zealand Free Trade Agreement. Submission to Ministry of Foreign Affairs & Trade

(EC) ), 11(8) 347/ /2009, (EC)

Rethinking the role of Social Sciences and Humanities (SSH) in Horizon 2020: toward a reflective and generative perspective

GENEVA COMMITTEE ON DEVELOPMENT AND INTELLECTUAL PROPERTY (CDIP) Fifth Session Geneva, April 26 to 30, 2010

April 2015 newsletter. Efficient Energy Planning #3

Development of the Strategic Research Agenda of the Implementing Geological Disposal of Radioactive Waste Technology Platform

UN GA TECHNOLOGY DIALOGUES, APRIL JUNE

Joint NAM S&T Centre ACENTDFB Fellowship in Neglected Tropical Diseases and Forensic Biotechnology

G7 SCIENCE MINISTERS COMMUNIQUÉ

Report on the Results of. Questionnaire 1

SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry

The ESF Mission. ESF provides a common platform for its Member Organisations (MOs) in order to:

School of Informatics Director of Commercialisation and Industry Engagement

Strategic Plan for CREE Oslo Centre for Research on Environmentally friendly Energy

Implementing the International Safety Framework for Space Nuclear Power Sources at ESA Options and Open Questions

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

DRAFT TEXT on. Version 2 of 9 September 13:00 hrs

Title of Presentation

OBSTACLES AND OPPORTUNITIES FOR THE PECS INDUSTRY TO PARTICIPATE IN ESA PROGRAMMES SPACE4SME PROJECT. Prague April 25, 2008

Roadmap of Cooperative Activities

EUROPEAN MANUFACTURING SURVEY EMS

Supporting medical technology development with the analytic hierarchy process Hummel, Janna Marchien

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes

Exploring emerging ICT-enabled governance models in European cities

Tuning-CALOHEE Assessment Frameworks for the Subject Area of CIVIL ENGINEERING The Tuning-CALOHEE Assessment Frameworks for Civil Engineering offers

BIM Policy Development: Different Countries, Common Approaches

RESEARCH AND INNOVATION STRATEGY

COMMISSION STAFF WORKING DOCUMENT STRATEGY FOR EUROPEAN TECHNOLOGY PLATFORMS: ETP 2020

Twinning cases selected Deliverable D3.2 INNO-Partnering Forum

Digitisation Plan

Canadian Network for Innovative Shipbuilding, Marine Research and Training (CISMaRT):

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL. on the evaluation of Europeana and the way forward. {SWD(2018) 398 final}

Technology Needs Assessments under GEF Enabling Activities Top Ups

PACIFIC SCIENCE AND TECHNOLOGY ADVISORY GROUP TO UNISDR (PSTAG)

EXECUTIVE SUMMARY RESEARCH INTELLIGENCE DRIVING HEALTH SYSTEM TRANSFORMATION IN CANADA

Selecting, Developing and Designing the Visual Content for the Polymer Series

ACTIVITY REPORT OF THE NATIONAL INDUSTRIAL COMPETITIVENESS COMMISSION PRAMONĖ 4.0 OF 2017

Innovation Systems and Policies in VET: Background document

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

TECHNOLOGY ENABLED CARE Supporting Service Transformation Delivery Plan 2018/19

Research Ecologist British Trust for Ornithology

Performance evaluation and benchmarking in EU-funded activities. ICRA May 2011

Standing Committee on the Law of Patents

Supportive publishing practices in DRR: Leaving no scientist behind

Research Brief. Clinicians and life sciences companies working together: What types of relationships do clinicians find most appealing?

Engineering Change Lab (Eng Lab) UNLOCKING THE POTENTIAL OF THE ENGINEERING PROFESSION IN CANADA SYSTEMICALLY, EXPERIMENTALLY & COLLABORATIVELY

Final Report. MAASiFiE. Report Nr 1.2 May 2017

Transcription:

Page 1 of 5 Call for Proposals for "Working Groups for Harmonisation and Alignment in Brain Imaging Methods for Neurodegeneration" Final version January 2016 Submission deadline for proposals: 10 th March 2016, 23:59h C.E.T. For further information, please visit us on the web http://www.jpnd.eu/ or contact the JPND joint call secretariat: Dr. Constanze Hahn Constanze.Hahn@dlr.de (+49) 228-3821 1865 Dr. Thomas Becker Thomas.Becker@dlr.de (+49) 228-3821 1686

Page 2 of 5 The trans-national 30-member state Joint Programme - Neurodegenerative Disease Research (JPND) is the largest global research initiative aimed at tackling the challenge of neurodegenerative disease (ND). JPND is pleased to launch a rapidaction call for leading scientists in the field to establish working groups to bring forward novel approaches to enhance the use of brain imaging for neurodegenerative disease research. The working groups must address innovative and new ideas within the area of brain imaging. The working groups will be community-led and will establish best practice guidelines and/or methodological frameworks to overcome barriers regarding the use of brain imaging in ND research. The call is not intended to support direct research studies. Supported groups will provide outputs within a 9 month timeframe that will be of value to the broader ND research community. These will be made available through the JPND website. Guidelines will be used for further JPND actions. 1. Background to the call Imaging techniques such as MR, PET, and EEG mapping have brought about a dramatic improvement in the understanding of early development and progression of brain changes in persons with cognitive disorders of old age such as Alzheimer s disease. Advances have been made in the past few years regarding access to state-of-the-art and cutting edge imaging technology, harmonisation of acquisition procedures across scanners and vendors, and access to platforms for advanced image analysis. However, a number of challenges are apparent looking forward; such as undertaking multi-centre clinical trials of an unprecedented scale, facilitating multimodal connectivity and data transfer across imaging centres, and the use of imaging for diagnostics and/or to measure clinical outcomes. These issues will require new methodologies and an ability to undertake image acquisition and analysis at scale and at the global level. Any new ideas that will encourage harmonization and alignment in brain imaging will be welcome. As examples, the following aspects have been identified that might merit further attention by the scientific expert community: Harmonisation of acquisition for current markers Development of multi-vendor/model acquisition and harmonization of procedures, for example for MR, FDG PET, and EEG signals that are as independent as possible from operators for current disease markers to be used in multi-centre studies (e.g. defining acquisition sequences and parameters; developing data quality assurance protocols and automated quality assurance analytical tools; building a repository for acquisition protocol information, analysis pipelines, and exemplar data). Simplification of web access to image analysis environments Improving the secure access to innovative web-based image analysis environments for neurodegenerative diseases, thereby facilitating data upload, download, exchange and expansion to other services (e.g. quality control, image analysis pipelines, statistical analysis including machine learning technologies for biomarker research, data management services, archiving, customized data sharing). Promoting the development of innovative PET molecular markers Fostering the use of established and experimental PET methods for the development of innovative PET molecular ligands (e.g. providing novel PET tracers and standardized data analysis, facilitating the use of PET tracers in multidisciplinary studies, developing innovative multimodal data analysis techniques for standardized and efficient use in multi-centre studies). Innovative ultra-high field (UHF) MR markers Development of innovative imaging markers based on UHF MR (e.g. listing candidates

Page 3 of 5 for disease specific UHF imaging markers with new diagnostic significance on a functional, structural or molecular level; pooling data and expertise; developing optimized and standardised data acquisition and analysis protocols). There will of course be other imaging concepts worthy of consideration. JPND has decided that such issues can be progressed most effectively through assembling motivated groups of leading experts in the ND field. Accordingly community-led Working Groups are to be supported that can push forward the conceptualization of such topics in order to provide guidelines and/or best practice frameworks of value to the wider research community. Synergies with and linkage to other existing major initiatives in brain imaging are encouraged. 2. Focus of the call To establish a limited number of JPND-sponsored expert Working Groups to address issues of key relevance for the future use of brain imaging techniques in ND research. Areas to be considered are highlighted above, although any other topics that are similar in theme and relevance may be proposed. The following neurodegenerative diseases are included in the call: Alzheimer s disease and other dementias Parkinson s disease and PD- related disorders Prion diseases Motor neuron diseases Huntington s disease Spinocerebellar ataxia (SCA) Spinal muscular atrophy (SMA). Studies primarily relevant to other diseases with a neurodegenerative component (e. g., multiple sclerosis) are not included in the call. 3. Characteristics and mode of operation of Working Groups Involve key opinion leaders with an internationally competitive track record in ND research and/or neuroimaging. The core membership will be drawn from within JPND member countries. However, the inclusion of experts from other countries beyond JPND is encouraged. Led by an individual with the energy and commitment to drive a collaborative and output-directed process. This individual need not be the most senior person in the group. Guided by a clear project plan. A typical arrangement would entail small workshops at the beginning and end of the process, with sub-groups established to achieve more focused work through remoteworking. Consideration should be given to establishing an external reference group to ensure that objectivity is maintained in developing the Working Group's conclusions and recommendations. 4. Funds available and form of support Each working group can bid up to 50,000 for support of its activities, which are expected to run for a maximum of 9 months with the possibility for the country funding agencies to approve an extension of up to 12 months in total. Funding will cover the costs of meetings and travel required to deliver the Working Groups' objectives

Page 4 of 5 It is expected the budget will allow for two small workshops, with further work to be undertaken through email, tele-, video- or web-conferencing. A working group might organize a joint workshop for exchange of results between all working groups. For such an activity, another up to 50.000 may be requested. Applications should indicate whether or not working groups are interested in organizing this workshop and a case will be requested from relevant award holders at a later date. This funding will not provide support for: direct research activity; equipment; the salaries of investigators or scientific staff, although funds to part-support an administrative co-coordinator for the activity will be permitted; student stipends. 5. Eligibility Applications are to be led by a coordinator from an eligible institution within one of the participating JPND member countries (in accordance with the Terms and Conditions of the relevant national funding organisations). As a cross-jpnd activity, experts from all JPND member countries may participate in Working Groups, including countries who are not financial participants to the call. In addition, Working Groups are encouraged to include key expertise from non-jpnd countries. The JPND countries contributing funding to this call are: Canada, Canadian Institutes of Health Research Denmark, Innovation Fund Denmark France, French National Research Agency* Germany, Federal Ministry of Education and Research Ireland, Health Research Board Italy, Ministry of Health Netherlands, The Netherlands Organisation for Health Research and Development Norway, The Research Council of Norway Spain, National Institute of Health Carlos III* Sweden, Swedish Research Council Switzerland, Swiss National Science Foundation United Kingdom, Medical Research Council * Pending final decision Only trans-national research groups will be funded. To qualify for funding, each proposal must involve research experts from three or more of the 30 JPND countries. Working Group contributors are permitted to be members of Working Groups in more than one proposal. However, individuals may not act as the Coordinator for more than one proposal. The best proposals and funding priorities will be identified following assessment, as detailed in section 8.

Page 5 of 5 Following the review, a JPND Sponsor Group will align working groups with the funding available. There will be the flexibility to do this because groups are expected to have members from at least three and probably many more countries. 6. Outputs Working Groups are required to produce a report at the end of the funding period that contains guidelines or a methodological framework, to be published on the JPND website. This report is expected to act as a reference point for the wider ND research community in planning and delivering future research studies. Applicants should also put forward an appropriate plan to disseminate the outcomes, for example, through publication in a journal. A common workshop will be organized at the end of the process to bring together and present the combined outputs from the Working Groups funded under this call, to encourage further cross-fertilisation of ideas and wider dissemination to stakeholder groups. 7. Applications Applicants will be required to cover the following: the rationale for the proposed activity, identifying the research-need or barrier to progress being addressed; why the outputs (whether guidelines or a methodological framework) will uniquely contribute to moving ND research forward; the positioning of the proposed activity relative to related activity being pursued through existing neuroimaging initiatives the objectives and mode of operation of the Working Group, specifying the workplan and timeline for delivery; the identity of the experts to be involved, specifying the leadership /coordinator for the exercise; where appropriate, the identity of experts who will act as an advisory reference group for the process to help validate the outputs; a breakdown of the budget request; the expected outcomes and deliverables, including plans for dissemination. Applications must be submitted by the coordinator in electronic format no later than 23:59h C.E.T. on March 10, 2016 via the electronic submission system (https://www.ptit.de/ptoutline/application/imaging). No other means of submission will be accepted. The proposal template is available through the JPND website (http://www.neurodegenerationresearch.eu/initiatives/annual-calls-for-proposals/brain-imagingworking-groups-2016/). 8. Assessment Criteria Applications will be assessed by an international and independent review group. Applications will be assessed on the following criteria: The scientific fit to the call The distinctiveness and likely impact of the activity The timeliness and relevance of the ideas proposed for discussion The standing of the experts within the proposed working group and whether as a group they have the appropriate mix of scientific skills The feasibility and appropriateness of the project plan Plans for dissemination and the potential impact of the outcomes to the field 9. Awards Awards will be made on a national basis by the relevant funding organisations and administered according to their terms and conditions, taking into account all other applicable regulations and legal frameworks. Successful projects are expected to start in 2016.

10. Enquiries For any enquiries please contact the JPND Joint Call Secretariat: Page 6 of 5 Dr. Constanze Hahn Constanze.Hahn@dlr.de (+49) 228-3821 1865 Dr. Thomas Becker Thomas.Becker@dlr.de (+49) 228-3821 1686